Kumar, A.S. and Samuel, V. 2025. Cost-Effectiveness of Co-Amoxiclav Versus Clindamycinin the Treatment of Uncomplicated Soft Tissue Infections in a Tertiary Care Hospital. Journal of Health and Technology. 1, 1 (Mar. 2025), 15–22. DOI:https://doi.org/10.65129/clinical.v1i1.25.